News

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
In clinical trials, semaglutide proved to be superior to placebo, with weight loss reaching 15%, suggesting its superiority over other non-GLP-1 RA anti-obesity medications. Participants ...
WeightWatchers has filed for bankruptcy in the US as it faces mounting debt amid a boom in the use of GLP-1 weight-loss drugs ...
Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
A young mum has shared an honest account of her weight loss journey after her health took a frightening turn while surviving ...